(Reuters) — Federal officials are investigating how Abbott Laboratories Inc. has marketed the epilepsy drug Depakote, the company said on Friday, the latest U.S. probe of its sales practices. The suburban Chicago drugmaker said in a regulatory filing that the federal prosecutor for the ...

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News